Joint Hypertension Scientific Sessions

The latest news from the AHA Council on Hypertension, AHA Council on Kidney in Cardiovascular Disease and American Society of Hypertension joint meeting, with physician perspective, researcher interviews and clinician insight.

Meeting News Coverage

ALPINE: Atherosclerosis progression increased with renin inhibition

May 23, 2013
MRI quantification demonstrated that renin inhibition with aliskiren resulted in an “unexpected” increase in aortic atherosclerosis as…
Meeting News Coverage

ALPINE: Atherosclerosis progression increased with renin inhibition

Cardiology Today, August 2013
MRI quantification demonstrated that renin inhibition with aliskiren resulted in an “unexpected” increase in aortic atherosclerosis as…
Meeting News Coverage

Healthy providers more likely to urge hypertension prevention

May 20, 2013
Primary care providers’ own behavior was associated with clinical recommendations for hypertension prevention in adult patients, according to…
Meeting News Coverage

Many patients may have received inappropriate DAPT dose

HemOnc Today, December 25, 2012
LOS ANGELES — Approximately 75% of patients receiving dual antiplatelet therapy with a P2Y12 inhibitor are receiving the wrong dose, according…
Meeting News Coverage

Many patients may have received inappropriate DAPT dose

Cardiology Today, January 2013
LOS ANGELES — Approximately 75% of patients receiving dual antiplatelet therapy with a P2Y12 inhibitor are receiving the wrong dose, according…
Meeting News CoveragePerspectivePublication Exclusive

ARCTIC: Antiplatelet therapy not improved by monitoring platelet function

HemOnc Today, December 25, 2012
LOS ANGELES — New data from the ARCTIC study suggest that adjusting antiplatelet therapy based on platelet-function monitoring did not lead to…
Meeting News CoveragePerspectivePublication Exclusive

ARCTIC: Antiplatelet therapy not improved by monitoring platelet function

Cardiology Today, January 2013
LOS ANGELES — New data from the ARCTIC study suggest that adjusting antiplatelet therapy based on platelet-function monitoring did not lead to…
Meeting News Coverage

ASPIRE: VTE recurrence similar with aspirin, placebo

Endocrine Today, December 2012
LOS ANGELES — Aspirin failed to reduce venous thromboembolism recurrence but was linked to reductions in CV events compared with placebo…
Meeting News CoveragePerspectivePublication Exclusive

CARRESS HF: Pharmacologic care superior to ultrafiltration for acute decompensated HF

Cardiology Today, January 2013
LOS ANGELES — Hospitalized patients with acute decompensated HF had better outcomes with use of a stepped pharmacologic-therapy algorithm as…
Meeting News CoveragePerspectivePublication Exclusive

RELAX-AHF: Serelaxin improved symptoms, CV mortality in hospitalized HF patients

Cardiology Today, December 2012
LOS ANGELES — New results from the RELAX-AHF trial indicate that the investigational drug serelaxin improved signs and symptoms of HF…